Joanna Melia

Joanna Melia

Auto-generated profile, based on publicly available information

Joanna Melia

Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, MD

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2024 in NEJM AI
Verified
Journal Article
Closed access
CZCyril Zakka
Cyril Zakka
RSRohan Shad
Rohan Shad
ACAkash Chaurasia
Akash Chaurasia
ADAlex R. Dalal
Alex R. Dalal
JKJennifer L. Kim
Jennifer L. Kim
WHWilliam Hiesinger
William Hiesinger
Large language models (LLMs) have recently shown impressive zero-shot capabilities, whereby they can use auxiliary data, without the availability of task-specific training examples, to complete a variety of natural language tasks, such as summarization, dialogue generation, and question answering. However, despite many promising applications of LLMs in clinical medicine, adoption of these models has been limited by their tendency to generate incorrect and sometimes even harmful statements. We tasked a panel of eight board-certified clinicians and two health care practitioners with evaluating Almanac, an LLM framework augmented with retrieval capabilities from curated medical resources for medical guideline and treatment recommendations. The panel compared responses from Almanac and standard LLMs (ChatGPT-4, Bing, and Bard) versus a novel data set of 314 clinical questions spanning nine medical specialties. Almanac showed a significant improvement in performance compared with the standard LLMs across axes of factuality, completeness, user preference, and adversarial safety. Our results show the potential for LLMs with access to domain-specific corpora to be effective in clinical decision-making. The findings also underscore the importance of carefully testing LLMs before deployment to mitigate their shortcomings. (Funded by the National Institutes of Health, National Heart, Lung, and Blood Institute.).

15 October 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
LSLaxmi Sunuwar
Laxmi Sunuwar
AFAzra Frkatović
Azra Frkatović
SSSodbo Sharapov
Sodbo Sharapov
QWQinchuan Wang
Qinchuan Wang
HNHeather M. Neu
Heather M. Neu
JMJoanna Melia
Joanna Melia
ZIP8 is a metal transporter with a role in manganese (Mn) homeostasis. A common genetic variant in ZIP8 (rs13107325; A391T) ranks in the top 10 of pleiotropic SNPs identified in GWAS; A391T has associations with an increased risk of schizophrenia, obesity, Crohn’s disease, and reduced blood Mn. Here, we used CRISPR/ Cas9 -mediated knockin (KI) to generate a mouse model of ZIP8 A391T (Zip8 393T-KI mice). Recapitulating the SNP association with blood Mn, blood Mn was reduced in Zip8 393T-KI mice. There was restricted abnormal tissue Mn homeostasis, with decreases in liver and kidney Mn and a reciprocal increase in biliary Mn, providing in vivo evidence of hypomorphic Zip8 function. Upon challenge in a chemically induced colitis model, male Zip8 393T-KI mice exhibited enhanced disease susceptibility. ZIP8 391-Thr associated with reduced triantennary plasma N-glycan species in a population-based cohort to define a genotype-specific glycophenotype hypothesized to be linked to Mn-dependent glycosyltransferase activity. This glycophenotype was maintained in a cohort of patients with Crohn’s disease. These data and the pleiotropic disease associations with ZIP8 391-Thr suggest underappreciated roles of Mn homeostasis in complex human disease.

1 July 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JMJoanna M.P. Melia
Joanna M.P. Melia
RLRuxian Lin
Ruxian Lin
RXRamnik J. Xavier
Ramnik J. Xavier
RTRichard B. Thompson
Richard B. Thompson
DFDax Fu
Dax Fu
MDMark Donowitz
Mark Donowitz

9 November 2023 in Gastro Hep Advances
Verified
Journal Article
Open access
JAJulia Angkeow
Julia Angkeow
ARAlissa Rothman
Alissa Rothman
LCLara Chaaban
Lara Chaaban
NPNicole Paul
Nicole Paul
JMJoanna Melia
Joanna Melia
Approximately 1 in 4 patients with ulcerative colitis experiences a severe exacerbation of disease requiring hospitalization, termed acute severe ulcerative colitis (ASUC). These episodes pose a major burden on patients with ulcerative colitis and early prediction of their outcomes based on clinical data is crucial to optimize therapy. A systematic review was performed using Embase and Medline for articles between 2000 and 2023. Studies obtained from the databases were uploaded on Covidence for screening by 2 independent reviewers. Quality appraisal for each study was done using the Critical Appraisals Skills Program depending on study design. A total of 48 eligible studies were included in the review. The key predictors of ASUC identified in this review included clinical, endoscopic, and radiographic biomarkers, which were summarized. The main outcomes assessed in the studies were intravenous corticosteroid failure, need for rescue therapy, and need for colectomy. Score-based predictions and some novel markers were also included in the results. Utilization of evidence-based predictors of outcome in ASUC could serve as a powerful tool in customizing therapeutic measures and a step forward toward personalized patient care. Despite promising candidates, there remains a significant opportunity to identify and test additional clinical and laboratory-based predictors, especially early in the hospitalization and as the clinical practice and medical therapies evolve.

30 January 2024 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
KBKristi Briggs
Kristi Briggs
VTVartika Tomar
Vartika Tomar
NONicholas Ollberding
Nicholas Ollberding
YHYael Haberman
Yael Haberman
ABArno R Bourgonje
Arno R Bourgonje
JMJoanna M P Melia
Joanna M P Melia
Background: A pathogenic mutation in the manganese transporter ZIP8 (A391T; rs13107325) increases the risk of Crohn’s disease. ZIP8 regulates manganese homeostasis and given the shared need for metals between the host and resident microbes, there has been significant interest in alterations of the microbiome in carriers of ZIP8 A391T. Prior studies have not examined the ileal microbiome despite associations between ileal disease and ZIP8 A391T. Methods: Here, we used the Pediatric Risk Stratification Study (RISK) cohort to perform a secondary analysis of 16S ribosomal RNA gene sequencing data obtained from ileal and rectal mucosa to study associations between ZIP8 A391T carrier status and microbiota composition. Results: We found sequence variants mapping to Veillonella were decreased in the ileal mucosa of ZIP8 A391T carriers. Prior human studies have demonstrated the sensitivity of Veillonella to bile acid abundance. We therefore hypothesized that bile acid homeostasis is differentially regulated in carriers of ZIP8 A391T. Using a mouse model of ZIP8 A391T, we demonstrate an increase in total bile acids in the liver and stool and decreased fibroblast growth factor 15 (Fgf15) signaling, consistent with our hypothesis. We confirmed dysregulation of FGF19 in the 1000IBD cohort, finding that plasma FGF19 levels are lower in ZIP8 A391T carriers with ileocolonic Crohn’s disease. Conclusions: In the search for genotype-specific therapeutic paradigms for patients with Crohn’s disease, these data suggest targeting the FGF19 pathway in ZIP8 A391T carriers. Aberrant bile acid metabolism may precede development of Crohn’s disease and prioritize study of the interactions between manganese homeostasis, bile acid metabolism and signaling, and complicated ileal Crohn’s disease.

10 August 2023 in The FASEB Journal
Verified
Journal Article
Closed access
LSLaxmi Sunuwar
Laxmi Sunuwar
VTVartika Tomar
Vartika Tomar
AWAsia Wildeman
Asia Wildeman
VCValeria Culotta
Valeria Culotta
JMJoanna Melia
Joanna Melia